Imunon, Inc. (IMNN) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 3 Buy, 1 Hold.
Analysts estimate Earnings Per Share (EPS) of $-21.91 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.72 vs est $-21.91 (beat +92.2%). 2025: actual $-6.83 vs est $-7.13 (beat +4.2%). Analyst accuracy: 0%.
IMNN Analyst Ratings
Buy
Based on 4 analysts giving stock ratings to Imunon, Inc. in the past 3 months
EPS Estimates — IMNN
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.72
vs Est –$21.91
▲ 1,174.0% off
2025
Actual –$6.83
vs Est –$7.13
▲ 4.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — IMNN
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
